• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠股动静脉瘘模型:静脉狭窄处基质金属蛋白酶-2和-9表达增加。

The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis.

作者信息

Misra Sanjay, Fu Alex A, Anderson Jill L, Sethi Sanjeev, Glockner James F, McKusick Michael A, Bjarnason Haraldur, Woodrum David A, Mukhopadhyay Debabrata

机构信息

Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55905, USA.

出版信息

J Vasc Interv Radiol. 2008 Apr;19(4):587-94. doi: 10.1016/j.jvir.2008.01.005.

DOI:10.1016/j.jvir.2008.01.005
PMID:18375305
Abstract

PURPOSE

To determine whether a femoral arteriovenous (AV) fistula model in a rat was feasible and whether there is increased expression of matrix metalloproteinase (MMP)-2 and -9 and the tissue inhibitors of MMPs (TIMPs) at the venous stenosis of the fistula.

MATERIALS AND METHODS

Fifteen male Sprague-Harley rats weighing 353 g +/- 26 underwent creation of an AV fistula between the left femoral artery and ipsilateral femoral vein, with the contralateral femoral vessels serving as controls. The animals were euthanized at day 14 (n = 5) and day 28 (n = 10) after fistula creation. Zymography and Western blot analysis for TIMP-1 and TIMP-2 were performed at the venous stenosis and in control vessels. Hematoxylin and eosin, Verhoeff-van Gieson, Masson trichrome, and alpha-smooth muscle staining were performed at the stenosis and in controls at day 28 in four animals. The intima/media ratio was determined at day 28.

RESULTS

By day 14, pro-MMP-2 measurements were 8.13 +/- 1.06 at the venous stenosis and 4.1 +/- 1.33 in controls (P < .05). By day 28, they had increased to 18.95 +/- 4.8 at the stenosis and 12.11 +/- 4.84 in controls (P < .05). By day 14, active MMP-2 measurements were 7.38 +/- 1.25 at the stenosis and 2.31 +/- 1.04 in controls (P < .05). By day 28, they had increased to 12.12 +/- 3.45 at the stenosis and 9.26 +/- 3.97 in controls (P < .05). By day 28, pro-MMP-9 measurements were 11.77 +/- 4.71 at the stenosis and 7.78 +/- 3.49 in controls (P < .05), with no difference at day 14. There was no difference in expression of TIMP-1 and TIMP-2. The average intima/media ratio of the stenosis increased by 28% versus controls, and the neointima was composed of primarily alpha-smooth muscle actin-positive cells.

CONCLUSIONS

A rat femoral AV fistula model was created with venous stenosis formation characterized by thickened neointima composed of alpha-smooth muscle actin-positive cells compared with controls. At the venous stenosis, there was increased expression of pro-MMP-2 and active MMP-2 by days 14 and 28, with significantly increased expression of pro-MMP-9 by day 28.

摘要

目的

确定大鼠股动静脉(AV)瘘模型是否可行,以及在瘘管静脉狭窄处基质金属蛋白酶(MMP)-2和-9及其组织抑制剂(TIMP)的表达是否增加。

材料与方法

15只体重353 g±26 g的雄性Sprague-Harley大鼠,在左股动脉和同侧股静脉之间建立AV瘘,对侧股血管作为对照。在造瘘后第14天(n = 5)和第28天(n = 10)对动物实施安乐死。在静脉狭窄处和对照血管处进行TIMP-1和TIMP-2的酶谱分析和蛋白质印迹分析。在第28天,对4只动物的狭窄处和对照处进行苏木精-伊红染色、Verhoeff-van Gieson染色、Masson三色染色和α-平滑肌染色。在第28天测定内膜/中膜比值。

结果

到第14天,静脉狭窄处前MMP-2的测量值为8.13±1.06,对照处为4.1±1.33(P < 0.05)。到第28天,狭窄处升至18.95±4.8,对照处为12.11±4.84(P < 0.05)。到第14天,狭窄处活性MMP-2的测量值为7.38±1.25,对照处为2.31±1.04(P < 0.05)。到第28天,狭窄处升至12.12±3.45,对照处为9.26±3.97(P < 0.05)。到第28天,狭窄处前MMP-9的测量值为11.77±4.71,对照处为7.78±3.49(P < 0.05),第14天无差异。TIMP-1和TIMP-2的表达无差异。狭窄处的平均内膜/中膜比值比对照增加了28%,新生内膜主要由α-平滑肌肌动蛋白阳性细胞组成。

结论

建立了大鼠股AV瘘模型,其静脉狭窄形成的特征是与对照相比,新生内膜增厚,由α-平滑肌肌动蛋白阳性细胞组成。在静脉狭窄处,第14天和第28天时前MMP-2和活性MMP-2的表达增加,到第28天时前MMP-9的表达显著增加。

相似文献

1
The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis.大鼠股动静脉瘘模型:静脉狭窄处基质金属蛋白酶-2和-9表达增加。
J Vasc Interv Radiol. 2008 Apr;19(4):587-94. doi: 10.1016/j.jvir.2008.01.005.
2
The mouse arteriovenous fistula model.小鼠动静脉瘘模型。
J Vasc Interv Radiol. 2009 Jul;20(7):946-50. doi: 10.1016/j.jvir.2009.03.044.
3
An animal model of venous hypertension: the role of inflammation in venous valve failure.静脉高压动物模型:炎症在静脉瓣膜功能衰竭中的作用。
J Vasc Surg. 2005 Feb;41(2):303-11. doi: 10.1016/j.jvs.2004.10.038.
4
Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.大鼠实验性动静脉瘘的重塑与基质金属蛋白酶表达增加
J Vasc Surg. 2007 Apr;45(4):804-11. doi: 10.1016/j.jvs.2006.12.063.
5
Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.实验性静脉瓣膜功能不全的机制及其被500毫克达弗隆(地奥司明)的修正作用
Eur J Vasc Endovasc Surg. 2008 Jan;35(1):102-10. doi: 10.1016/j.ejvs.2007.08.011. Epub 2007 Sep 24.
6
[The role of changes of MMP-2, 9 activity in the development of liver fibrosis in rats].[基质金属蛋白酶-2、9活性变化在大鼠肝纤维化发生发展中的作用]
Zhonghua Gan Zang Bing Za Zhi. 2004 May;12(5):267-70.
7
Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model.基质金属蛋白酶抑制可限制啮齿动物动静脉瘘模型中的动脉扩张。
Surgery. 1998 Aug;124(2):328-34; discussion 334-5.
8
Hypertension-induced venous valve remodeling.高血压诱导的静脉瓣膜重塑。
J Vasc Surg. 2004 Jun;39(6):1329-34. doi: 10.1016/j.jvs.2004.02.044.
9
Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.皮质发育过程中的蛋白水解活性与缺氧缺血性损伤中涉及的蛋白水解活性不同。
Neuroscience. 2009 Jan 23;158(2):732-44. doi: 10.1016/j.neuroscience.2008.07.069. Epub 2008 Aug 14.
10
Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.大鼠卵圆细胞肝再生过程中基质金属蛋白酶-2、-9及基质金属蛋白酶组织抑制因子-1的表达
Matrix Biol. 2008 Oct;27(8):674-81. doi: 10.1016/j.matbio.2008.07.002. Epub 2008 Jul 16.

引用本文的文献

1
Vessel Wall Histologic Changes in a Porcine Model of Arteriovenous Fistula Stenosis Treated with Percutaneous Transluminal Angioplasty.经皮腔内血管成形术治疗猪动静脉内瘘狭窄模型的血管壁组织学变化
J Vasc Interv Radiol. 2025 Apr;36(4):660-669.e3. doi: 10.1016/j.jvir.2024.12.023. Epub 2024 Dec 24.
2
Vascular and Perivascular Role in the Regulation of Angiogenesis: Impact on Arteriovenous Fistula Maturation.血管及血管周围在血管生成调控中的作用:对动静脉内瘘成熟的影响
Arch Intern Med Res. 2024;7(4):284-296. doi: 10.26502/aimr.0185. Epub 2024 Nov 27.
3
Development of a Porcine Model of Arteriovenous Fistula Venous Stenosis Treated with Percutaneous Transluminal Angioplasty.
经皮腔内血管成形术治疗猪动静脉内瘘静脉狭窄模型的建立。
J Vasc Interv Radiol. 2025 Feb;36(2):332-339.e10. doi: 10.1016/j.jvir.2024.10.020. Epub 2024 Oct 25.
4
Building a Scaffold for Arteriovenous Fistula Maturation: Unravelling the Role of the Extracellular Matrix.构建动静脉瘘成熟的支架:解析细胞外基质的作用。
Int J Mol Sci. 2023 Jun 28;24(13):10825. doi: 10.3390/ijms241310825.
5
A Murine Model of Hemodialysis Access-related Hand Dysfunction.血液透析通路相关手部功能障碍的小鼠模型。
J Vis Exp. 2022 May 31(183). doi: 10.3791/63892.
6
Development of a murine iliac arteriovenous fistula model for examination of hemodialysis access-related limb pathophysiology.用于研究血液透析通路相关肢体病理生理学的小鼠髂动静脉内瘘模型的建立。
JVS Vasc Sci. 2021 Oct 6;2:247-259. doi: 10.1016/j.jvssci.2021.09.022. eCollection 2021.
7
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.MMP-9 缺失通过减少血管炎症反应来减轻动静脉瘘术后新生内膜。
Int J Mol Sci. 2021 May 21;22(11):5448. doi: 10.3390/ijms22115448.
8
Effect of galectin-3 in the pathogenesis of arteriovenous fistula stenosis formation.半乳糖凝集素-3 在动静脉瘘狭窄形成中的作用。
Ren Fail. 2021 Dec;43(1):566-576. doi: 10.1080/0886022X.2021.1902822.
9
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.基质金属蛋白酶 MMP-2 和 MMP-9、它们的抑制剂 TIMP-1 和 TIMP-2、血管内皮生长因子和 sVEGFR-2 作为系统性硬化症患者缺血性视网膜病变的预测标志物:病例系列报告。
Int J Mol Sci. 2020 Nov 18;21(22):8703. doi: 10.3390/ijms21228703.
10
Differences in Transforming Growth Factor-β1/BMP7 Signaling and Venous Fibrosis Contribute to Female Sex Differences in Arteriovenous Fistulas.转化生长因子-β1/骨形态发生蛋白 7 信号通路的差异导致动静脉瘘女性性别差异。
J Am Heart Assoc. 2020 Aug 18;9(16):e017420. doi: 10.1161/JAHA.120.017420. Epub 2020 Aug 6.